Clinical Trial Update: A Study to Investigate Biomarkers After Single Doses of Anticoagulants in Healthy Young Male and Healthy Elderly Participants (MK-0000-216 AM1) [Phase 1]

View source ↗

Summary

This Phase 1 study investigated biomarker changes after single doses of anticoagulants in healthy young and elderly participants.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thrombosis

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Thrombosis | Phase 1 | Status: COMPLETED